Coya Therapeutics Files 8-K Report
Ticker: COYA · Form: 8-K · Filed: Sep 2, 2025 · CIK: 1835022
| Field | Detail |
|---|---|
| Company | Coya Therapeutics, Inc. (COYA) |
| Form Type | 8-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $4.2 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, other-event
TL;DR
Coya Therapeutics filed an 8-K on 8/29. Details on the 'Other Event' pending.
AI Summary
On August 29, 2025, Coya Therapeutics, Inc. filed an 8-K report. The filing indicates an 'Other Event' occurred on this date, but the specific details of this event are not elaborated within the provided text. The company is incorporated in Delaware and its principal executive offices are located in Houston, Texas.
Why It Matters
This filing signals a material event has occurred for Coya Therapeutics, Inc., requiring public disclosure. Investors should look for further details to understand the event's impact.
Risk Assessment
Risk Level: medium — The filing indicates an 'Other Event' without providing specifics, creating uncertainty for investors.
Key Numbers
- 001-41583 — Commission File Number (Identifies the company's SEC filing history)
Key Players & Entities
- Coya Therapeutics, Inc. (company) — Registrant
- August 29, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Houston, Texas (location) — Principal Executive Offices
FAQ
What specific 'Other Event' is Coya Therapeutics, Inc. reporting on August 29, 2025?
The provided text of the 8-K filing does not specify the details of the 'Other Event'.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 29, 2025.
In which state is Coya Therapeutics, Inc. incorporated?
Coya Therapeutics, Inc. is incorporated in Delaware.
What is the principal executive office address for Coya Therapeutics, Inc.?
The principal executive offices are located at 5850 San Felipe St., Suite 500, Houston, Texas 77057.
What is the Commission File Number for Coya Therapeutics, Inc.?
The Commission File Number is 001-41583.
Filing Stats: 484 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-09-02 08:30:25
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share COYA The Nasdaq Stock Mar
- $4.2 million — a Therapeutics Inc. ("Coya") received a $4.2 million milestone payment from its strategic pa
Filing Documents
- d95745d8k.htm (8-K) — 23KB
- 0001193125-25-193450.txt ( ) — 137KB
- coya-20250829.xsd (EX-101.SCH) — 3KB
- coya-20250829_lab.xml (EX-101.LAB) — 18KB
- coya-20250829_pre.xml (EX-101.PRE) — 11KB
- d95745d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COYA THERAPEUTICS, INC. Date: September 2, 2025 By: /s/ Arun Swaminathan Ph.D. Arun Swaminathan Ph.D. Chief Executive Officer